Top 5 worldwide oncology products by revenue 2017 and 2024

Published by
Matej Mikulic,
Dec 10, 2024
This statistic displays the oncology products (cancer drugs) worldwide ranked by projected revenue in 2024, and their revenues in 2017. The drug Opdivo from Bristol-Myers and Squibb is expected to generate around 11.2 billion U.S. dollars in revenue in 2024. Oncology deals with cancer, including diagnosis, therapy, as well as palliative care.

Top 5 oncology products worldwide based on revenue in 2017 and 2024 (in million U.S. dollars)*

© Statista 2024
Download
Show detailed source information?
Register for free
Already a member?
Log in
Source

Use Ask Statista Research Service

Release date

June 2018

Region

Worldwide

Survey time period

as of May 2018

Supplementary notes

* Oncology includes: Alkaloids, alkylating agents, anti-metabolites, anti-neoplastic MAbs, cancer vaccines, cytotoxic antibiotics, cormone therapies, platinum compounds and other anti-cancer. Excludes anti-emetics and anti-anaemics used in chemotherapy-induced anaemia. Also excludes: Interferons, immunostimulants & immunosuppressants.
The products are ranked by 2024 revenues.
* Projected.

Open this statistic in...
Spanish
Citation formats
Access all statistics starting from $2,388 USD yearly *

* For commercial use only

Basic Account

For single users
$0 USD
Always free
Access limited to Free Statistics. Premium Statistics are not included.
  • Free Statistics
Based on your interests

Starter Account

For single users
$199 USD
per month, billed annually 1
Buy now
  • Free Statistics
  • Premium Statistics

    • The statistic on this page is a Premium Statistic and is included in this account.

Professional Account

For teams of up to 5 people
$959 USD
per month, billed annually 1
Buy now
  • Free + Premium Statistics
  • Reports
  • Market Insights

1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.

Compare accounts

Statistics on " Oncology "

The most important statistics
The most important statistics
The most important statistics
The most important statistics
The most important statistics
The most important statistics
The most important statistics
The most important statistics

Other statistics that may interest you Oncology

Cancer facts

5

Oncology market

6

Companies

7

Cancer drugs

5

Research and development

6

Immuno-oncology

5

Treatment types

5

Physicians and patients

8

Further related statistics

19

Further Content: You might find this interesting as well

Statistics

Topics

RocheGlobal pharmaceutical industryJohnson & JohnsonNovartisCancer in the U.S.
Access all statistics starting from $2,388 USD yearly *

* For commercial use only

Basic Account

For single users
$0 USD
Always free
Access limited to Free Statistics. Premium Statistics are not included.
  • Free Statistics
Based on your interests

Starter Account

For single users
$199 USD
per month, billed annually 1
Buy now
  • Free Statistics
  • Premium Statistics

    • The statistic on this page is a Premium Statistic and is included in this account.

Professional Account

For teams of up to 5 people
$959 USD
per month, billed annually 1
Buy now
  • Free + Premium Statistics
  • Reports
  • Market Insights

1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.

Compare accounts
Learn more about how Statista can support your business.